loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 26361 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Alkermes Plc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Alkermes Plc (1)

    filter

    01 N1752 EXTENDED RELEASE TABLETS, 18MG (1)

    filter

    01 Ireland (1)

    filter

    01 Inactive (1)

    filter

    01 Blank (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    ALKERMES INC

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N1752 EXTENDED RELEASE TABLETS, 18MG

    PDF Supplier PDF
    URL Supplier Web Content
    26361
    Inactive
    2012-08-28
    N/A
    II
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Drug Master Files (DMF) for 26361 of Alkermes Inc

    Looking for Drug Master Files (DMF) for 26361 of Alkermes Inc 1

    20

    Alkermes Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is N1752 EXTENDED RELEASE TABLETS, 18MG, with a corresponding US DMF Number 26361.

    Remarkably, this DMF maintains an Inactive status since its submission on August 28, 2012, highlighting commitment to regulatory compliance.

    Post Enquiry
    POST ENQUIRY